Semaglutide Compare Semaglutide Compare
Semaglutide Compare

Is Ozempic licensed for weight loss in the UK?

Last reviewed: 2026-05-23 Reviewer: Weight Loss Comparison

No. In the UK, Ozempic is not the semaglutide brand licensed for weight loss. Wegovy is the semaglutide brand used for obesity and weight management, which is why UK provider pages often move from Ozempic search intent into Wegovy wording or weight-loss comparison context.

Licence question

Ozempic and Wegovy are not interchangeable brand labels in UK weight-loss comparison

The confusion comes from the fact that both products contain semaglutide. Ingredient overlap does not make the licensed public comparison identical. When a UK visitor asks whether Ozempic is licensed for weight loss, the clean answer is no, and the cleaner next route is usually Wegovy.

This matters because provider pages, pricing and checkout wording become much easier to read once the brand-role distinction is clear.

01

Ingredient

Both products contain semaglutide.

02

Licence

Wegovy is the semaglutide brand for obesity and weight management.

03

Comparison

That is why Wegovy pages usually give the cleaner private weight-loss comparison lane.

What “licensed” changes

Why the licensing point matters on comparison sites

Cleaner provider wording

Providers are generally clearer when describing Wegovy availability, starting doses and later-dose prices.

Less search confusion

Ozempic searches often mix diabetes branding, semaglutide interest and weight-loss intent into the same query.

More reliable dose comparison

Wegovy price ladders are usually easier to compare than public Ozempic-context pages on UK private weight-loss sites.

Safer interpretation

Once the licence point is clear, it becomes easier to read whether a provider page is offering a route or simply explaining one.

What you will see on provider pages

Why private provider pages still mention Ozempic

They mention it because people search for it. Some use it to explain semaglutide, some use it to compare it with Wegovy, and some use it to say explicitly that Ozempic is not the weight-loss brand they are supplying. That is why an Ozempic page can exist on a UK provider site without meaning that the provider is offering a clean, dedicated Ozempic weight-loss route.

Lloyds Pharmacy

Uses the page mainly to explain the route and clarify availability.

Better next pages

Where to compare from here

Ozempic alternatives

Compare the stronger private routes if your real question is treatment rather than brand history.

Source checks

Provider Pages Route To Wegovy

Reviewed provider pages often use Ozempic to capture or clarify semaglutide searches, then move the comparison into Wegovy or broader weight-management context.

Checked: 23 May 2026 Confidence: Medium

Source: Superdrug Online Doctor Ozempic page

Used for the provider-page interpretation section.

View source

NICE Semaglutide Weight Management

NICE has semaglutide guidance for managing overweight and obesity, which supports the weight-management route context around semaglutide in the UK.

Checked: 23 May 2026 Confidence: High

Source: NICE TA875 semaglutide for managing overweight and obesity

Used to support the UK weight-management route context around semaglutide.

View source

Emc Ozempic Diabetes Indication

Ozempic has UK product information on the electronic medicines compendium as a prescription medicine for type 2 diabetes rather than a weight-loss brand.

Checked: 23 May 2026 Confidence: High

Source: eMC Ozempic SmPC

Used for the medicine-status and indication point.

View source

NHS Weight Loss Brand Role

NHS medicines guidance identifies Wegovy as the semaglutide brand used to treat obesity, while Ozempic is one of the common semaglutide brands used to manage type 2 diabetes.

Checked: 23 May 2026 Confidence: High

Source: NHS medicines: Semaglutide

Used for the core answer on licensing and brand role.

View source

Source check: Brand role, provider wording, public pricing and availability can change. Confirm current details directly with the provider before taking the next step.